What initial synchronized cardioversion energy (in joules) should be used when the rhythm may be atrial fibrillation or supraventricular tachycardia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Initial Synchronized Cardioversion Energy for Uncertain AF vs SVT

When uncertain whether the rhythm is atrial fibrillation or supraventricular tachycardia, start with 150 joules using a biphasic waveform for synchronized cardioversion 1.

Rationale and Evidence Hierarchy

The 2020 Canadian Cardiovascular Society guidelines provide the most direct recommendation for this clinical scenario, explicitly stating that at least 150 J biphasic waveform should be used as the initial energy setting for direct current cardioversion (DCCV) 1. This recommendation prioritizes avoiding repeated shocks after ineffective low-energy attempts, which is particularly relevant when the specific rhythm type is uncertain.

Energy Requirements by Rhythm Type

When you cannot definitively distinguish between AF and SVT, the 150 J starting point represents a pragmatic middle ground:

  • Atrial fibrillation typically requires higher energy (100-150 J for biphasic waveforms) 2
  • Atrial flutter/atrial tachycardia may respond to lower energies (50 J can be effective) 2, 3
  • Starting at 150 J ensures adequate energy for AF while remaining safe for SVT variants 1

Clinical Algorithm

For hemodynamically unstable patients:

  • Proceed immediately to synchronized cardioversion at 150 J biphasic 4
  • Do not delay for rhythm clarification
  • Have atropine and pacing capability immediately available for post-cardioversion pauses 1

For hemodynamically stable patients:

  • Consider adenosine first if SVT is suspected (90-95% effective for AVRT) 4
  • If rhythm remains uncertain or adenosine fails, proceed to 150 J synchronized cardioversion 4, 1

Important Caveats

Biphasic vs monophasic waveforms matter significantly. The 150 J recommendation applies specifically to biphasic waveforms. Older monophasic defibrillators required substantially higher energies (200-360 J) 5, 6, but these are largely obsolete in modern practice.

Pre-excited atrial fibrillation is a critical exception. If you suspect Wolff-Parkinson-White with AF (irregular wide-complex tachycardia), proceed urgently to cardioversion as this can degenerate to ventricular fibrillation 4. Never use AV nodal blocking agents (adenosine, beta-blockers, calcium channel blockers) in this scenario.

Post-cardioversion arrhythmias are common. Atrial or ventricular premature complexes immediately after cardioversion may reinitiate tachycardia in 25% of cases 2, 3. Have antiarrhythmic drugs available if needed to prevent acute recurrence 4.

Escalation Strategy

If 150 J fails:

  • Second shock: 200 J
  • Third shock: 360 J (maximum for biphasic) 1, 2

Research data supports that most successful cardioversions occur within the first two shocks; patients requiring more than two attempts have significantly lower success rates 2, 7.

Sedation Requirements

Two trained operators are ideal: one managing sedation and airway, another managing the synchronized cardioversion 1. Adequate sedation or anesthesia is essential for stable patients to minimize discomfort and patient movement that could desynchronize the shock.

Related Questions

What are the recommended synchronized cardioversion energy levels for different arrhythmias such as sustained monomorphic ventricular tachycardia, atrial fibrillation, atrial flutter, and atrial tachycardia (AVNRT/AVRT)?
What are the recommended joules for electrical cardioversion in adults for atrial fibrillation, atrial flutter, and other supraventricular tachyarrhythmias?
What is the appropriate evaluation and management for a 16-year-old patient with no prior medical history who presents with fluctuating pulse tachycardia?
What is the recommended energy level for cardioversion (cardioversion is a medical procedure that uses electrical shocks to convert an abnormal heart rhythm to a normal one) in a patient with a history of difficult-to-convert arrhythmias or previous unsuccessful cardioversion attempts, considering starting at 100-150 Joules and potentially increasing to 250 Joules?
In an adult patient with supraventricular tachycardia (SVT), when is cardioversion indicated and what are the recommended synchronized shock energy settings and sedation regimen?
How accurate is FibroScan (transient elastography) in assessing liver fibrosis?
How should I manage a red eye with unchanged vision and conjunctival redness that spares the cornea?
Are days 1–10 of the menstrual cycle considered part of the follicular phase?
Can a patient on Simponi (golimumab) safely receive the annual influenza vaccine, and should it be the inactivated injection rather than the live‑attenuated intranasal form?
What is the appropriate treatment for facial bruising?
Which form of vitamin K is appropriate for topical treatment of bruising?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.